| Texto completo | |
| Autor(es): Mostrar menos - |
Klauss, P. H. A.
;
Hi, E. M. B.
;
Bianchi, C. C. R.
;
Ruiz, A. U.
;
de Barros, M. F. C. B.
;
da Silva, B. M.
;
Moretto, T. L.
;
Soriano, F. G.
;
Curi, R.
;
Machado, M. C. C.
;
Gritte, R. B.
Número total de Autores: 11
|
| Tipo de documento: | Artigo Científico |
| Fonte: | Brazilian Journal of Medical and Biological Research; v. 57, p. 11-pg., 2024-01-01. |
| Resumo | |
SARS-CoV-2 is a novel coronavirus that infects the respiratory tract and was the causing agent of COVID-19, declared a pandemic by the World Health Organization on March 11, 2020. Several studies have been carried out to understand the pathophysiology of the disease, immune reactions, and risk factors that could aggravate the condition and predict the prognosis of patients. Therefore, this study aimed to evaluate the most prevalent laboratory data of hospitalized patients associated with discharge or death. A survey was conducted utilizing the medical records of COVID-19 cases in patients treated in the intensive care unit of the Guilherme & Aacute;lvaro Hospital in the seaside city of Santos, Brazil. We correlated the most important variables reported in the literature to provide a global comparison of the population affected by the virus in the Santos lowlands. (AU) | |
| Processo FAPESP: | 23/07917-9 - Pesquisa de autoanticorpos em pacientes que tiveram covid-19 de forma leve, moderada e grave. |
| Beneficiário: | Camille Cosme Rodrigues Bianchi |
| Modalidade de apoio: | Bolsas no Brasil - Iniciação Científica |
| Processo FAPESP: | 22/02109-9 - Síndrome pós COVID: sequelas imunologicas pós infecção por COVID 19 |
| Beneficiário: | Raquel Bragante Gritte |
| Modalidade de apoio: | Bolsas no Brasil - Pós-Doutorado |
| Processo FAPESP: | 21/08624-0 - Síndrome pós-COVID: sequelas imunológicas pós infecção por COVID-19 |
| Beneficiário: | Marcel Cerqueira Cesar Machado |
| Modalidade de apoio: | Auxílio à Pesquisa - Regular |